Abstract: A composition for preventing and/or treating cytokine release syndrome and a method of prevention and/or treatment of cytokine release syndrome are disclosed. The composition includes an aryl ethene compound, a pharmaceutically acceptable salt thereof, or a solvate thereof, as an active ingredient. The method includes administering the aryl ethene compound, an isomer, a pharmaceutically acceptable salt thereof, or a solvate thereof, in an effective amount to a subject in need thereof. The cytokine release syndrome may be caused by virulent infection. The administration of the compound reduces the pre-inflammatory cytokine levels in the subject.
Type:
Application
Filed:
August 4, 2021
Publication date:
February 10, 2022
Applicant:
NovMetaHealth Co., Ltd
Inventors:
In-Kyu LEE, Jae-Han JEON, Dipanjan CHANDA, Eun Jung CHOI, Hoe-Yune JUNG, Heon Jong LEE
Abstract: A composition for preventing and/or treating pancreatitis and a method of prevention and/or treatment of pancreatitis are disclosed. The composition include an aryl ethene compound, a pharmaceutically acceptable salt thereof, or a solvate thereof, as an active ingredient. The method includes administering the aryl ethene compound, an isomer, a pharmaceutically acceptable salt thereof, or a solvate thereof, in an effective amount to a subject in need thereof.
Type:
Application
Filed:
June 22, 2020
Publication date:
December 23, 2021
Applicant:
NovMetaHealth Co., Ltd.
Inventors:
Heon Jong LEE, Hoe Yune JUNG, In-Kyu LEE, Jae-Han JEON, Sung Jin CHO